Prognostic Factors in Operable Breast Cancer
Author Information
Author(s): RA Hawkins, AL Tesdalel, ME Killen, WJL Jack, U Chetty, JM Dixon, MJ Hulme, RJ Prescott, MA McIntyre, WR Miller
Primary Institution: University Department of Surgery, Royal Infirmary NHS Trust, Edinburgh
Hypothesis
Can specific biochemical markers predict outcomes in operable breast cancer?
Conclusion
Tumour estrogen receptor concentration, axillary nodal status, and tumour grade are the most important prognostic factors in the early years after presentation of operable breast cancer.
Supporting Evidence
- ER concentration was significantly related to disease-free interval and death.
- Node status and tumour grade were also significant prognostic factors.
- Only ER concentration and node status were significant for risk of death.
- Clinical tumour size contributed slightly to the risk of distant recurrence.
Takeaway
Doctors can better predict how breast cancer will behave by looking at certain markers in the tumor, like estrogen levels and lymph node involvement.
Methodology
The study included 215 patients with operable breast cancer, analyzing four biochemical markers and their relationship to clinical outcomes over a median follow-up of 36.2 months.
Potential Biases
Potential biases may arise from the exclusion of patients with previous malignancies and the reliance on specific biochemical assays.
Limitations
The study had a relatively short follow-up period and focused on a single clinical unit, which may limit the generalizability of the findings.
Participant Demographics
The study involved 215 women with operable breast cancer, treated at a single breast unit.
Statistical Information
P-Value
<0.0001
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website